IRIS - Res&Arch Institutional Research Information System - Research & Archive

CANNALIRE, ROLANDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 654
EU - Europa 444
AS - Asia 170
Totale 1.268
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 654
IT - Italia 192
IE - Irlanda 119
HK - Hong Kong 57
SG - Singapore 51
CN - Cina 35
DE - Germania 24
VN - Vietnam 21
RU - Federazione Russa 20
SE - Svezia 18
BE - Belgio 17
FI - Finlandia 14
UA - Ucraina 8
GB - Regno Unito 7
RO - Romania 7
CH - Svizzera 4
CZ - Repubblica Ceca 4
NL - Olanda 4
FR - Francia 3
KR - Corea 3
AT - Austria 2
JP - Giappone 2
LB - Libano 1
PT - Portogallo 1
Totale 1.268
Salva come PNG Salva come JPEG
Città #
Chandler 173
Dublin 119
Perugia 103
Hong Kong 57
San Mateo 50
Singapore 42
Altamura 39
Boardman 33
Medford 26
Princeton 26
Lawrence 24
Wilmington 24
Dong Ket 20
Fremont 20
Redmond 19
Spoleto 18
Brussels 17
Beijing 14
Redwood City 14
Dearborn 12
Falls Church 12
Andover 10
Saint Petersburg 10
Des Moines 9
Bucharest 7
Ann Arbor 6
Jacksonville 6
Norwalk 6
Los Angeles 5
Ashburn 4
Dallas 4
Den Haag 4
Helsinki 4
Munich 3
Nanjing 3
Vigodarzere 3
Campegine 2
Frankfurt Am Main 2
Hanover 2
Jinan 2
Naples 2
Olomouc 2
San Giustino 2
Tokyo 2
Umbertide 2
Xian 2
Aachen 1
Absecon 1
Alfa 1
Buffalo 1
Böblingen 1
Büdelsdorf 1
Chengdu 1
Chicago 1
Fairfield 1
Falkenstein 1
Fuzhou 1
Hanoi 1
Hebei 1
Houston 1
Kunming 1
Landshut 1
London 1
Milan 1
Monmouth Junction 1
Moscow 1
Nanchang 1
Nanning 1
Napoli 1
Phoenix 1
Reggio Nell'emilia 1
Rome 1
San Diego 1
San Paolo di Civitate 1
Santa Clara 1
Seoul 1
Shaoxing 1
Simi Valley 1
Verona 1
Weimar 1
Zurich 1
Totale 1.001
Salva come PNG Salva come JPEG
Nome #
Functionalized 2,1-benzothiazine 2,2-dioxides as new inhibitors of Dengue NS5 RNA-dependent RNA polymerase 91
2-Phenylquinoline S. aureus NorA Efflux Pump Inhibitors: Evaluation of the Importance of Methoxy Group Introduction 76
Discovery of potent p38α MAPK inhibitors through a funnel like workflow combining in silico screening and in vitro validation 68
The Pyrazolobenzothiazine Core as a New Chemotype of p38 Alpha Mitogen-Activated Protein Kinase Inhibitors 64
Structure-based insights into p38α MAPK: from crystal structures analysis to hit optimization 63
Advantageous Use of Ionic Liquids for the Synthesis of Pharmaceutically Relevant Quinolones 63
Pyridobenzothiazolones Exert Potent Anti-Dengue Activity by Hampering Multiple Functions of NS5 Polymerase 63
Studies on 2-phenylquinoline Staphylococcus aureus NorA efflux pump inhibitors: New insights on the C-6 position 60
A Journey around the Medicinal Chemistry of Hepatitis C Virus Inhibitors Targeting NS4B: From Target to Preclinical Drug Candidates 59
Broad spectrum anti-flavivirus pyridobenzothiazolones leading to less infective virions 57
Searching for Novel Inhibitors of the S. aureus NorA Efflux Pump: Synthesis and Biological Evaluation of the 3-Phenyl-1,4-benzothiazine Analogues 55
C-2 phenyl replacements to obtain potent quinoline-based Staphylococcus aureus NorA inhibitors 55
Design and synthesis of WM5 analogues as HIV-1 TAR RNA binders. 52
Targeting flavivirus RNA dependent RNA polymerase through a pyridobenzothiazole inhibitor 49
Evolution of HCV NS4B Inhibitors 49
New Pyrazolobenzothiazine Derivatives As Hepatitis C Virus NS5B Polymerase Palm Site I Inhibitors 49
Broad-Spectrum Flavivirus Inhibitors: a Medicinal Chemistry Point of View 48
Ethidium bromide exposure unmasks an antibiotic efflux system in Rhodococcus equi 45
Mode of action of the 2-phenylquinoline efflux inhibitor PQQ4R against Escherichia coli 42
Boosting Effect of 2-Phenylquinoline Efflux Inhibitors in Combination with Macrolides against Mycobacterium smegmatis and Mycobacterium avium 40
Modifications on C6 and C7 Positions of 3-Phenylquinolone Efflux Pump Inhibitors Led to Potent and Safe Antimycobacterial Treatment Adjuvants 39
Tumour cell population growth inhibition and cell death induction of functionalized 6-aminoquinolone derivatives 37
From Quinoline to Quinazoline-Based S. aureus NorA Efflux Pump Inhibitors by Coupling a Focused Scaffold Hopping Approach and a Pharmacophore Search 37
The versatile nature of the 6-aminoquinolone scaffold: identification of submicromolar hepatitis C virus NS5B inhibitors 36
Natural isoflavone biochanin A as a template for the design of new and potent 3-phenylquinolone efflux inhibitors against Mycobacterium avium 36
An overview on small molecules acting as broad-spectrum agents for yellow fever infection 33
Visible light photocatalysis in the late-stage functionalization of pharmaceutically relevant compounds 29
Totale 1.395
Salva come PNG Salva come JPEG
Categoria #
all - tutte 6.291
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.291
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202072 0 0 0 0 0 16 18 3 6 22 3 4
2020/2021187 9 11 1 11 47 31 38 3 5 4 3 24
2021/2022286 6 37 1 8 18 5 21 56 35 16 31 52
2022/2023496 28 110 8 43 43 48 0 23 171 2 16 4
2023/2024177 11 41 5 1 0 3 56 3 4 7 24 22
2024/202559 1 32 24 2 0 0 0 0 0 0 0 0
Totale 1.395